Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-100129
Filing Date
2025-10-20
Accepted
2025-10-20 06:58:25
Documents
5
Period of Report
2025-10-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0261762-6k_immuron.htm 6-K 12130
2 EMERGING GROWTH CONFERENCE ea026176201ex99-1_immuron.htm EX-99.1 25803
3 GRAPHIC ex99-1_001.jpg GRAPHIC 17461
4 GRAPHIC ex99-1_002.jpg GRAPHIC 21005
5 GRAPHIC ex99-1_003.jpg GRAPHIC 10372
  Complete submission text file 0001213900-25-100129.txt   106672
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 251402288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)